5 unknown, 2 completed, 1 withdrawn. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Unknown 5, Completed 2, Withdrawn 1 |
Follow apatinib: new trials by email Literature Review of apatinib trials Research Report on apatinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 Therapy Apatinib - Gastric Cancer, Randomized Controlled Study | Phase 4 | Unknown | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 60 | 2021-08-26 | 2021-08-31 |
| Pemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based Regimen Apatinib, Pemetrexed - Advanced Non-squamous Non-small-cell Lung Cancer | Phase 4 | Withdrawn | Xinqiao Hospital of Chongqing | 2019-02-01 | 2024-02-28 | |
| Apatinib for Advanced Lung Squmamous Carcinoma Apatinib - Lung Squamous Cell Carcinoma | Phase 4 | Unknown | Xuzhou Central Hospital | 50 | 2018-10-01 | 2018-10-31 |
| Treatment of Newly Diagnosed Peripheral T-cell Lymphoma Apatinib, CHOP Regimen - Newly Diagnosed Peripheral T-cell Lymphoma | Phase 4 | Unknown | Zhengzhou University | 100 | 2018-09-01 | 2018-08-15 |
| Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker Correlations apatinib - Stage IV Cancer | Phase 4 | Unknown | Sun Yat-sen University | 217 | 2018-02-26 | 2020-05-12 |
| Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma Apatinib - Relapsed and Refractory, Diffuse Large B Cell Lymphoma | Phase 4 | Completed | Zhengzhou University | 32 | 2017-01-01 | 2019-07-25 |
| The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. Apatinib - Malignancies, Stomach Cancer | Phase 4 | Completed | Shandong Cancer Hospital and Institute | 38 | 2016-09-30 | 2018-02-20 |
| A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy Apatinib Mesylate Tablets - Gastric Cancer | Phase 4 | Unknown | Tianjin Medical University Cancer Institute and Hospital | 40 | 2016-04-01 | 2016-05-20 |
Stomach Neoplasms (3) · Neoplasms (2) · Ovarian Neoplasms (2) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Esophageal Neoplasms (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, T-Cell, Peripheral (1) · Recurrence (1) · Uterine Cervical Neoplasms (1)
Zhengzhou University (2) · Shandong Cancer Hospital and Institute (1) · Sun Yat-sen University (1) · Tianjin Medical University Cancer Institute and Hospital (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1) · Xinqiao Hospital of Chongqing (1) · Xuzhou Central Hospital (1)
China (7)
Han Liang, Master (1) · Mingzhi Zhang, Pro,Dr (1) · Shuanghu Yuan, MD;PhD (1) · Tao Zhang, Doctor (1) · Xiang Wang, Master (1)